ImmunoGen, Inc. Profile Avatar - Palmy Investing

ImmunoGen, Inc.

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase…
Biotechnology
US, Waltham [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Value per Employee (VpE)

ImmunoGen, Inc. can't present you any valid VpE charts.

Employee Surveys Sample Size: -

There is no qualitative & current survey we can present at the moment.

Talent Acquisition

Permanent Employees Green Cards
Latest 12 Months
Employees
n/A
Wage Range
Min.:$n/A
Avg.:$n/A
Max.:$n/A
High Demand:

ImmunoGen, Inc. can't present the data

Other Demand
  • Not available for ImmunoGen, Inc.
Temporary Employees H1Bs
Latest 12 Months
Employees
n/A
Wage Range
Min.:$n/A
Avg.:$n/A
Max.:$n/A
High Demand:

ImmunoGen, Inc. can't present the data

Other Demand
  • Not available for ImmunoGen, Inc.

geographical
binding & acquisition

U.S. · Company Locations
Worldwide · Talent Acquisition
End of IMGN's Analysis
CIK: 855654 CUSIP: 45253H101 ISIN: US45253H1014 LEI: - UEI: -
Secondary Listings